Participant flow

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) · Source last updated 2013-05-03

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Patients receive oral mycophenolate mofetil 1000 mg twice daily.

   id

   FG000

   title

   Mycophenolate Mofetil

2. description

   Patients receive oral placebo twice daily

   id

   FG001

   title

   Placebo

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         18

      2. group Id

         FG001

         num Subjects

         24

      type

      Termination of trial

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         74

      2. group Id

         FG001

         num Subjects

         77

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         56

      2. group Id

         FG001

         num Subjects

         53

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         18

      2. group Id

         FG001

         num Subjects

         24

      type

      NOT COMPLETED

   title

   Overall Study

recruitment Details

Clinic patients were recruited from May 2004 through June 2008.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice